CBO director to testify on health care reform
Executive Summary
Congressional Budget Office Director Douglas Elmendorf is scheduled to testify before the Senate Finance Committee Feb. 25 on health care reform from the budget perspective. The hearing will delve into the budget effect of various items that might be considered as part of the health care reform debate that were laid out in a report issued in December 2008 (1"The Pink Sheet," Dec. 22, 2008, p. 20). Committee Chairman Max Baucus has been front and center on the health care reform debate, including the issuance of a white paper in November that will serve as the foundation for debate over reform options (2"The Pink Sheet," Nov. 17, 2008, p. 16). Baucus plans to introduce reform legislation "in the first part of the year," the hearing announcement states
You may also be interested in...
US Q1 Consumer Health Earnings Preview: Label This One Historic And Challenging But Promising
US OTC drug and supplement firms’ reports of results for the first three months of 2024 began on April 19 with P&G. JP Morgan analysts say while “some retailers in the US in particular” are reducing consumer health inventories, for the overall sector they expect “a healthier balance of positive volume and lower pricing contribution.”
Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa
The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.
Partisan Politics Returns To US FDA Congressional Oversight
The US FDA has stood out as an agency that tends to draw broad bipartisan support amid a generally rancorous and divided Congress. A House hearing, however, may be a sign that those days are over.